Drug profile · INN
iomeprol
IOMERVU
iomeprol (IOMERVU) is a diagnostic. Route of administration: intra-arterial. Current US regulatory status: approved.
FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — iomeprol
- US status
- approved
- Class
- —
- Route
- INTRA-ARTERIAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
iomeprol (IOMERVU) is a diagnostic. Route of administration: intra-arterial. Current US regulatory status: approved.
Key facts
INN iomeprol
Brand IOMERVU
Mechanism Diagnostic
Route INTRA-ARTERIAL
Formulation SOLUTION
Mechanism of action
Diagnostic
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Frequently asked questions
What is iomeprol?
iomeprol (IOMERVU) is a diagnostic. Route of administration: intra-arterial. Current US regulatory status: approved.
What is the brand name for iomeprol?
IOMERVU is a marketed brand name for iomeprol. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of iomeprol?
iomeprol has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.